Ayukalp Uap Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.75 M
as on 23-10-2024
- Paid Up Capital ₹ 3.50 M
as on 23-10-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.39 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.55 Cr
as on 23-10-2024
- Revenue 14.13%
(FY 2023)
- Profit 24.18%
(FY 2023)
- Ebitda 89.68%
(FY 2023)
- Net Worth 14.24%
(FY 2023)
- Total Assets 15.24%
(FY 2023)
About Ayukalp Uap Pharma
The Corporate was formerly known as Unjha Ayupharma Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹6.39 Cr. The company has closed loans amounting to ₹3.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitinkumar Shah, Kuntal Shah, Veena Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1999PTC035977
- Company No.
035977
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ayukalp Uap Pharma Private Limited offer?
Ayukalp Uap Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup, Cardiovascular Drugs & Medication, Kidney Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Churna and Goli, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Ayukalp Uap Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitinkumar Shah  | Director | 11-May-1999 | Current |
| Kuntal Shah | Director | 17-Jan-2011 | Current |
| Veena Shah | Director | 17-Jan-2011 | Current |
| Kruti Shah | Director | 20-Apr-2019 | Current |
Financial Performance of Ayukalp Uap Pharma.
Ayukalp Uap Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.13% increase. The company also saw a substantial improvement in profitability, with a 24.18% increase in profit. The company's net worth Soared by an impressive increase of 14.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayukalp Uap Pharma?
Unlock access to Ayukalp Uap Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ayukalp Industries LimitedActive 29 years 8 monthsNitinkumar Shah, Kuntal Shah and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 03 Jun 2024 | ₹3.41 M | Open |
Hdfc Bank Limited Creation Date: 28 May 2024 | ₹2.55 Cr | Open |
Hdfc Bank Limited Creation Date: 10 Nov 2016 | ₹3.50 Cr | Open |
How Many Employees Work at Ayukalp Uap Pharma?
Ayukalp Uap Pharma has a workforce of 45 employees as of Sep 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayukalp Uap Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayukalp Uap Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
